日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysis

奥希替尼治疗T790M阳性晚期非小细胞肺癌日本患者:一项汇总亚组分析

Hirashima, Tomonori; Satouchi, Miyako; Hida, Toyoaki; Nishio, Makoto; Kato, Terufumi; Sakai, Hiroshi; Imamura, Fumio; Kiura, Katsuyuki; Okamoto, Isamu; Kasahara, Kazuo; Uchida, Hirohiko; Vowler, Sarah L; Mitsudomi, Tetsuya

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset

奥希替尼与标准EGFR-TKI一线治疗EGFR突变型晚期非小细胞肺癌的比较:FLAURA日本亚组研究

Ohe, Yuichiro; Imamura, Fumio; Nogami, Naoyuki; Okamoto, Isamu; Kurata, Takayasu; Kato, Terufumi; Sugawara, Shunichi; Ramalingam, Suresh S; Uchida, Hirohiko; Hodge, Rachel; Vowler, Sarah L; Walding, Andrew; Nakagawa, Kazuhiko

Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App

挖掘人类前列腺癌数据集:“camcAPP” Shiny 应用

Dunning, Mark J; Vowler, Sarah L; Lalonde, Emilie; Ross-Adams, Helen; Boutros, Paul; Mills, Ian G; Lynch, Andy G; Lamb, Alastair D

Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]

对“拷贝数和转录组学的整合为前列腺癌风险分层提供了可能:一项发现和验证队列研究”的更正[EBioMedicine 2 (9) (2015) 1133-1144]

Ross-Adams, H; Lamb, A D; Dunning, M J; Halim, S; Lindberg, J; Massie, C M; Egevad, L A; Russell, R; Ramos-Montoya, A; Vowler, S L; Sharma, N L; Kay, J; Whitaker, H; Clark, J; Hurst, R; Gnanapragasam, V J; Shah, N C; Warren, A Y; Cooper, C S; Lynch, A G; Stark, R; Mills, I G; Grönberg, H; Neal, D E

Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma

通过分析T2加权磁共振图像的异质性,可以区分胶质母细胞瘤的假性进展和进展。

Booth, Thomas C; Larkin, Timothy J; Yuan, Yinyin; Kettunen, Mikko I; Dawson, Sarah N; Scoffings, Daniel; Canuto, Holly C; Vowler, Sarah L; Kirschenlohr, Heide; Hobson, Michael P; Markowetz, Florian; Jefferies, Sarah; Brindle, Kevin M

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target

胆碱激酶α作为雄激素受体分子伴侣和前列腺癌治疗靶点

Asim, Mohammad; Massie, Charles E; Orafidiya, Folake; Pértega-Gomes, Nelma; Warren, Anne Y; Esmaeili, Mohsen; Selth, Luke A; Zecchini, Heather I; Luko, Katarina; Qureshi, Arham; Baridi, Ajoeb; Menon, Suraj; Madhu, Basetti; Escriu, Carlos; Lyons, Scott; Vowler, Sarah L; Zecchini, Vincent R; Shaw, Greg; Hessenkemper, Wiebke; Russell, Roslin; Mohammed, Hisham; Stefanos, Niki; Lynch, Andy G; Grigorenko, Elena; D'Santos, Clive; Taylor, Chris; Lamb, Alastair; Sriranjan, Rouchelle; Yang, Jiali; Stark, Rory; Dehm, Scott M; Rennie, Paul S; Carroll, Jason S; Griffiths, John R; Tavaré, Simon; Mills, Ian G; McEwan, Iain J; Baniahmad, Aria; Tilley, Wayne D; Neal, David E

Effects of fasting on serial measurements of hyperpolarized [1-(13) C]pyruvate metabolism in tumors

禁食对肿瘤中超极化[1-(13)C]丙酮酸代谢连续测量的影响

Serrao, Eva M; Rodrigues, Tiago B; Gallagher, Ferdia A; Kettunen, Mikko I; Kennedy, Brett W C; Vowler, Sarah L; Burling, Keith A; Brindle, Kevin M

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

整合拷贝数和转录组学数据可对前列腺癌进行风险分层:一项发现和验证队列研究

Ross-Adams, H; Lamb, A D; Dunning, M J; Halim, S; Lindberg, J; Massie, C M; Egevad, L A; Russell, R; Ramos-Montoya, A; Vowler, S L; Sharma, N L; Kay, J; Whitaker, H; Clark, J; Hurst, R; Gnanapragasam, V J; Shah, N C; Warren, A Y; Cooper, C S; Lynch, A G; Stark, R; Mills, I G; Grönberg, H; Neal, D E

5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer

5-羟甲基胞嘧啶标记结肠中的启动子可抵抗癌症中的 DNA 高甲基化

Santiago Uribe-Lewis, Rory Stark, Thomas Carroll, Mark J Dunning, Martin Bachman, Yoko Ito, Lovorka Stojic, Silvia Halim, Sarah L Vowler, Andy G Lynch, Benjamin Delatte, Eric J de Bony, Laurence Colin, Matthieu Defrance, Felix Krueger, Ana-Luisa Silva, Rogier Ten Hoopen, Ashraf Ek Ibrahim, François

HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network

HES6驱动关键的AR转录程序,通过激活E2F1介导的细胞周期网络诱导去势抵抗性前列腺癌。

Ramos-Montoya, Antonio; Lamb, Alastair D; Russell, Roslin; Carroll, Thomas; Jurmeister, Sarah; Galeano-Dalmau, Nuria; Massie, Charlie E; Boren, Joan; Bon, Helene; Theodorou, Vasiliki; Vias, Maria; Shaw, Greg L; Sharma, Naomi L; Ross-Adams, Helen; Scott, Helen E; Vowler, Sarah L; Howat, William J; Warren, Anne Y; Wooster, Richard F; Mills, Ian G; Neal, David E